Clinical trial
Special Drug Use Investigation for LAMICTAL Bipolar
NCT01428518 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Special Drug Use Investigation for LAMICTAL Bipolar
- Lead sponsor
- GlaxoSmithKline
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2011
- Completion date
- January 31, 2016
- Enrollment
- 1,036 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.